List View

By /

Clear

Displaying 1,126 - 1,150 of 2,995

Adjuvant and Neo-adjuvant Therapy for Lung Cancer

Adjuvant and Neo-adjuvant Therapy for Lung Cancer

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

Renal Cell Carcinoma (RCC): Current Approach to First Line Therapy and Beyond

Role of Immunotherapy in HNC

Role of Immunotherapy in HNC

Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate

Prostate Cancer: Role of PSMA PET and Accurately Defining “Neuroendocrine” Prostate

Immunotherapy for Breast Cancer: Updates and New Directions

Immunotherapy for Breast Cancer: Updates and New Directions

Antibody Drug Conjugates: New Agents and Optimal Sequencing

Antibody Drug Conjugates: New Agents and Optimal Sequencing

Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer

Endocrine Therapy and Targeted Agents for Early-Stage HR+ Breast Cancer

Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies

Endocrine Therapy for Advanced Breast Cancer: Current and Future Strategies

Ovarian Cancer: Beyond Carboplatin and Paclitaxel

Ovarian Cancer: Beyond Carboplatin and Paclitaxel

Role of ADCs in Gynecological Malignancies

Role of ADCs in Gynecological Malignancies

Current Status of Cervical Cancer Screening

Current Status of Cervical Cancer Screening

How Far Have We Gone with Biosimilars?

How Far Have We Gone with Biosimilars?

Anticoagulation in the Oncology Patient

Anticoagulation in the Oncology Patient

Liquid Biopsy

Liquid Biopsy

TNBC and Immunotherapy Developments in Breast Cancer

TNBC and Immunotherapy Developments in Breast Cancer

Guidelines for Hormone Therapy in Breast Cancer

Guidelines for Hormone Therapy in Breast Cancer

Challenges in Her-2 Breast Cancer

Challenges in Her-2 Breast Cancer

Disparities in Breast Cancer Therapy Outcomes

Disparities in Breast Cancer Therapy Outcomes

Immunotherapy for Early-Stage Lung Cancer: Adjuvant and Neoadjuvant Approaches

Immunotherapy for Early-Stage Lung Cancer: Adjuvant and Neoadjuvant Approaches

New Developments in Melanoma Early and Late Stage

New Developments in Melanoma Early and Late Stage

Establishing IO Management in Gastrointestinal Cancers

Establishing IO Management in Gastrointestinal Cancers

Immunotherapy for GYO Malignancies: Is There Still Time for Progress?

Immunotherapy for GYO Malignancies: Is There Still Time for Progress?

Immunotherapy for GU Malignancies and Exciting Developments

Immunotherapy for GU Malignancies and Exciting Developments

Developments in Gastric, and Esophageal Tumors

Developments in Gastric, and Esophageal Tumors

Targeted Therapy for Colon Cancer: What is New?

Targeted Therapy for Colon Cancer: What is New?